| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
|
Marshall, Deborah A.
|
|
|
23 |
5 |
p. 566-573
|
artikel
|
| 2 |
A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation
|
Niyomsri, Siwaporn
|
|
|
23 |
5 |
p. 656-665
|
artikel
|
| 3 |
Author's Reply
|
van der Pol, Simon
|
|
|
23 |
5 |
p. 675-676
|
artikel
|
| 4 |
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
|
Faulkner, Eric
|
|
|
23 |
5 |
p. 529-539
|
artikel
|
| 5 |
Competing Views on the English EQ-5D-5L Valuation Set
|
Norman, Richard
|
|
|
23 |
5 |
p. 574-575
|
artikel
|
| 6 |
Copyright/Subscription
|
|
|
|
23 |
5 |
p. v
|
artikel
|
| 7 |
Cost-Effectiveness of Radiofrequency Denervation for Patients With Chronic Low Back Pain: The MINT Randomized Clinical Trials
|
Maas, Esther T.
|
|
|
23 |
5 |
p. 585-594
|
artikel
|
| 8 |
Defining Comparators According to IQWiG’s Efficiency-Frontier Method
|
Gandjour, Afschin
|
|
|
23 |
5 |
p. 674-675
|
artikel
|
| 9 |
Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 Trials
|
Giesinger, Johannes M.
|
|
|
23 |
5 |
p. 666-673
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
23 |
5 |
p. vi
|
artikel
|
| 11 |
How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?
|
Trenaman, Logan
|
|
|
23 |
5 |
p. 576-584
|
artikel
|
| 12 |
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments
|
Aschmann, Hélène E.
|
|
|
23 |
5 |
p. 616-624
|
artikel
|
| 13 |
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019
|
Trosman, Julia R.
|
|
|
23 |
5 |
p. 551-558
|
artikel
|
| 14 |
Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects
|
DeWees, Todd A.
|
|
|
23 |
5 |
p. 625-631
|
artikel
|
| 15 |
Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy
|
Phillips, Kathryn A.
|
|
|
23 |
5 |
p. 527-528
|
artikel
|
| 16 |
Objective Estimates of Direct-Medical Costs Among Persons Aged 3 to 38 Years With and Without Research-Defined Autism Spectrum Disorder Ascertained During Childhood: A Population-Based Birth-Cohort Study
|
Leibson, Cynthia
|
|
|
23 |
5 |
p. 595-605
|
artikel
|
| 17 |
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing
|
Mackay, Zoë P.
|
|
|
23 |
5 |
p. 559-565
|
artikel
|
| 18 |
Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries
|
Govaerts, Laurenz
|
|
|
23 |
5 |
p. 606-615
|
artikel
|
| 19 |
Table of Contents
|
|
|
|
23 |
5 |
p. i-iv
|
artikel
|
| 20 |
The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program
|
Hernandez Alava, Monica
|
|
|
23 |
5 |
p. 642-648
|
artikel
|
| 21 |
The EQ-5D-5L Value Set for England: Response to the “Quality Assurance”
|
van Hout, Ben
|
|
|
23 |
5 |
p. 649-655
|
artikel
|
| 22 |
Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany
|
Hall, Rebecca
|
|
|
23 |
5 |
p. 632-641
|
artikel
|
| 23 |
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions
|
Deverka, Patricia A.
|
|
|
23 |
5 |
p. 540-550
|
artikel
|
Tijdschrift beschrijving